ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CLBT vs SPCX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Cellebrite DI Ltd. (NASDAQ) VS. Space Exploration Technologies Corp. (NASDAQ) • 15-METRIC TALLY: CLBT 4 — SPCX 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. SPCX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CLBT SPCX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 84.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.60% 58.30% -43.70 SPCX /roic <GO>
EV/EBITDA & P/E Valuation 38.1x 14.3x +23.80 SPCX /valuation <GO>
Free Cash Flow Yield 5.19% 3.99% +1.20 CLBT /fcf-yield <GO>
Operating Margin 14.00% 21.10% -7.10 SPCX /operating-margins <GO>
Net Profit Margin 16.50% 16.40% +0.10 CLBT /net-margins <GO>
Revenue Growth (YoY) 18.60% 20.90% -2.30 SPCX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.95 26.00 -21.05 SPCX /balance-sheet <GO>
Piotroski F-Score Quality 8/9 7/9 +1.00 CLBT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.9 45.9 +14.00 CLBT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.36 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 33.1x 18.2x +14.90 SPCX /forward-pe <GO>
Enterprise Scale & Market Cap $3.09B $1.95T -$1.95T SPCX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CLBT REV SPCX REV CLBT GROSS % SPCX GROSS % CLBT FCF SPCX FCF
FY 2025 $475.7M $0 84.2% — $160.3M $0
FY 2024 $401.2M — 84.4% — $123.6M —
FY 2023 $325.1M — — — $102.1M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
SPCX // BETA 1.36